MedPath

Evaluation of uveoretinitis associated with Behcet's disease after discontinuation of successful infliximab therapy

Not Applicable
Recruiting
Conditions
veoretinitis associated with Behcet&#39
s disease
Registration Number
JPRN-UMIN000025670
Lead Sponsor
Kyorin University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
6
Inclusion Criteria

Not provided

Exclusion Criteria

1)Patients with shortening of the interval between infliximab infusions 2)Patients with poor visual acuity during remission 3)Patients with neuro-Behcet's disease, intestinal Behcet's disease, vascular Behcet's disease

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Evaluation of frequency of ocular attacks
Secondary Outcome Measures
NameTimeMethod
Evaluation of visual acuity, fluorescein angiography, extraocular symptoms
© Copyright 2025. All Rights Reserved by MedPath